Related Experiment Video
Updated: Jul 23, 2026

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
Published on: May 22, 2019
Clinical Features and Outcome of Stroke with COVID-19. COVID-19 Stroke Study Group (CSSG), India
Rohit Bhatia1, M V Padma Srivastava1, P N Sylaja2
1Department of Neurology, All India Institute of Medical Sciences, New Delhi, India.
Insights
COVID-19 (Coronavirus Disease 19) significantly increases stroke severity and mortality. Patients with COVID-19 associated stroke (CoVS) experienced worse outcomes and higher death rates compared to those without the virus.
Area of Science:
- Neurology
- Infectious Diseases
- Public Health
Background:
- Stroke occurrence has been noted in patients diagnosed with COVID-19.
- Understanding the clinical impact of COVID-19 on stroke patients is crucial.
Purpose of the Study:
- To compare the clinical features and outcomes of stroke patients with and without COVID-19.
- To identify predictors of mortality in stroke patients during the pandemic.
Main Methods:
- A multicentric study involving 18 sites across India (COVID-19 Stroke Study Group).
- Comparison of stroke patients with (CoVS) and without (non-CoVS) COVID-19 admitted between February and July 2020.
- Collection of demographic, clinical, treatment, and outcome data.
Main Results:
- CoVS patients exhibited higher stroke severity and greater cerebral involvement on imaging.
- In-hospital complications, death rates, and 3-month mortality were significantly higher in CoVS patients.
- COVID-19 infection and baseline stroke severity independently predicted mortality.
Conclusions:
- COVID-19 associated stroke (CoVS) is linked to increased severity, poorer outcomes, and higher mortality.
- SARS-CoV-2 infection is an independent predictor of mortality in stroke patients.
Background And Purpose:
Occurrence of stroke has been reported among patients with COVID-19. The present study compares clinical features and outcomes of stroke patients with and without COVID-19.
Methods:
The COVID-19 Stroke Study Group (CSSG) is a multicentric study in 18 sites across India to observe and compare the clinical characteristics of patients with stroke admitted during the current pandemic period and a similar epoch in 2019. The present study reports patients of stroke with and without COVID-19 (CoVS and non-CoVS, respectively) seen between February 2020 and July 2020. Demographic, clinical, treatment, and outcome details of patients were collected.
Results:
The mean age and gender were comparable between the two groups. CoVS patients had higher stroke severity and extent of cerebral involvement on imaging. In-hospital complications and death were higher among CoVS patients (53.06% vs. 17.51%; P < 0.001) and (42.31% vs. 7.6%; P < 0.001), respectively. At 3 months, higher mortality was observed among CoVS patients (67.65% vs. 13.43%; P < 0.001) and good outcome (modified Rankin score [mRS]: 0-2) was seen more often in non-CoVS patients (68.86% vs. 33.33%; P < 0.001). The presence of COVID-19 and baseline stroke severity were independent predictors of mortality.
Conclusions:
CoVS is associated with higher severity, poor outcome, and increased mortality. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and baseline stroke severity are independent predictors of mortality.
Related Concept Videos
Stroke: Introduction and Types
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction

